# Wooshin Venture Investment

> Wooshin Venture Investment is a VC fund in Seoul backing Biotechnology and Pharmaceutical. See 30 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Seoul, South Korea
- Total investments: 30
- Last investment: Mar 2026
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.wooshinvc.com/

Wooshin Venture Investment is a VC fund in Seoul focused on Biotechnology and Pharmaceutical. Wooshin Venture Capital is the venture capital arm of Asia Cement Co. Ltd which invests in various range of sectors.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $3M–$15M |
| Series B | $8.9M–$20M |
| Series C | $17M–$30M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 6 | 20% |
| Pharmaceutical | 6 | 20% |
| Finance | 4 | 13% |
| Medical | 3 | 10% |
| Medical Device | 3 | 10% |

54 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 11 | 37% |
| Series A | 9 | 30% |
| Series C | 5 | 17% |
| Venture - Series Unknown | 2 | 7% |
| Seed | 1 | 3% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 21 | 70% |
| Malaysia | 1 | 3% |
| Singapore | 1 | 3% |
| United States | 1 | 3% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ark | Ark is an AI-based early screening company focused on identifying and preventing complications associated with chronic diseases, developing and supplying advanced medical AI solutions that enable early detection, risk assessment, and proactive disease management to support healthcare providers in delivering more precise and timely care. | $13.5M | Series A | Mar 05, 2026 |  |
| Goi | Goi provides funeral service support solutions that enables organizations to manage employee welfare and memorial arrangements efficiently. The company delivers an integrated suite of services, including real-time funeral coordination, cost control, customized memorial products, nationwide delivery, administrative assistance, and transparentpricing. This approach allows corporations and institutions to optimize employee benefit programs while ensuring families receive accessible, reliable, and dignified end-of-life services, reducing both financial burden and operational complexity. | $6.1M | Series A | Dec 01, 2025 |  |
| IMBiologics | IMBiologics is a biotechnology company that develops antibody-based drug candidates for diseases such as cancer and immune-related conditions. It conducts research and development using its own platforms to discover new therapeutic molecules. | $29.5M | Series C | Oct 14, 2025 |  |
| Z Enterprise | Z Enterprise is a finance and management firm that offers corporate financing, tax automation services, and computer and mobile apps. | $19.2M | Series C | Jun 09, 2025 |  |
| Dotter | Dotter is a manufacturing company that designs and produces biodegradable optical coherence tomography devices to diagnose and treat cardiovascular diseases. The company also develops next-generation OCT equipment, an optical imaging device that can create a synergy effect when inserting stents. | $7K |  | Dec 27, 2024 |  |
| Dotter | Dotter is a manufacturing company that designs and produces biodegradable optical coherence tomography devices to diagnose and treat cardiovascular diseases. The company also develops next-generation OCT equipment, an optical imaging device that can create a synergy effect when inserting stents. | $9.8M | Series B | Dec 27, 2024 |  |
| VESSL AI | VESSL AI enables machine learning teams to develop state-of-the-art models at scale without the complex and repetitive process of setting up pipelines and infrastructures.In addition to a centralized dashboard and workflow management, VESSL AI offers enterprise-grade infrastructure equipped with automated resource provisioning, and powerfultraining modes with automated hyperparameter optimization and multi-node distributed training. | $12.2M | Series A | Oct 07, 2024 |  |
| Paywatch | Paywatch offers a platform that allows employees to access their earnings before payday anytime. | $13.8M | Series A | Jun 24, 2024 |  |
| Paywatch Korea | Paywatch is a fintech company offering an Earned Wage Access (EWA) platform. It allows employees to access their earned salary before payday as a financial wellness benefit. The company also provides employee financial services like benefits, payments, and wage-linked solutions for employers and workers. | $14.4M | Series A | Jun 24, 2024 |  |
| MedInTech | Mediintech develops smart endoscopes for the digestive system. | $14.7M | Series B | May 13, 2024 |  |

10 of 30 investments shown.

## Co-investors
- [Atinum Partners](https://shizune.co/investors/profile/atinum-partners) — VC Fund, 5 deals together
- [Korea Investment & Securities](https://shizune.co/investors/profile/korea-investment-securities-d0c5) — VC Fund, 5 deals together
- [Shinhan Venture Investment](https://shizune.co/investors/profile/shinhan-venture-investment) — VC Fund, 5 deals together
- [Aju IB Investment](https://shizune.co/investors/profile/aju-ib-investment) — VC Fund, 4 deals together
- [K2 Investment Partners](https://shizune.co/investors/profile/k2-investment-partners) — VC Fund, 4 deals together
- [Kolon Investment](https://shizune.co/investors/profile/kolon-investment) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Coinbase Ventures](https://shizune.co/investors/profile/coinbase-ventures) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Finance Investors in South Korea](https://shizune.co/investors/finance-investors-south-korea)
- [Finance VC Funds in South Korea](https://shizune.co/investors/finance-vc-funds-south-korea)
- [Medical Device Investors in South Korea](https://shizune.co/investors/medical-device-investors-south-korea)
- [Medical Device VC Funds in South Korea](https://shizune.co/investors/medical-device-vc-funds-south-korea)
- [Proptech Investors in South Korea](https://shizune.co/investors/proptech-investors-south-korea)
- [Clean Energy Investors in South Korea](https://shizune.co/investors/clean-energy-investors-south-korea)

## FAQ

### What does Wooshin Venture Investment invest in?

Wooshin Venture Investment invests primarily in Biotechnology, Pharmaceutical and Finance startups, most often at Series B and Series A stage. Most of the 30 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Wooshin Venture Investment's check size?

Wooshin Venture Investment typically joins rounds of $3M–$15M at Series A, $8.9M–$20M at Series B and $17M–$30M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Wooshin Venture Investment participates in.

### When did Wooshin Venture Investment last invest?

The most recent investment recorded for Wooshin Venture Investment closed in Mar 2026. Shizune tracks 30 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co